Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…


ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to…


ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrop…

POPULAR TAGS

New strategic VIB - BioPontis Alliance for Rare Diseases

Written by LVS on in the category news with the tags , .


The VIB has announced its first research project in collaboration with the Biopontis Alliance for Rare Diseases. The study is aimed at developing a treatment for Charcot-Marie-Tooth disease and is part of a larger strategic partnership between the two institutes.

During the long-time collaboration, the institutes will focus on rare diseases. Although the cause of 4000 of the 7000 to 8000 rare diseases is known, few therapies are being developed and the field is in dire need of funding. Because of this, less than 5% of the patients suffering from a rare disease are being treated for their disorder.

One such rare disease is Charcot-Marie-Tooth (CMT) disease, a hereditary and highly debilitating neuropathy. The disease is caused by a genetic defect in the genes coding for different neuronal proteins, depending on the type of CMT disease. The result is consistently loss of muscle tissue, skeletal deformations and pain in the limbs.

The VIB-BioPontis partnership will combine excellent basic and translational research of VIB with BioPontis’ expertise in the development of therapies for rare diseases. The two institutes will also define new focus areas where progress can be made and where therapies can be developed efficiently.

Read more about: , .

RELATED ARTICLES
Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch…


ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to…


ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrop…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures GSK UGent Turnstone KU Leuven Janssen Flanders.bio Biowin Itera Life Science XpandInnovation

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.